Form 4: Cirrus Logic EVP Sells 8,913 Shares Under 10b5-1

EVP of Worldwide Sales Andrew Brannan exercised 8,001 options and sold 8,913 shares on November 14, 2025 under a Rule 10b5-1 plan, ending with 5,950 shares owned.

Summary

• Andrew Brannan (EVP, Worldwide Sales) reported multiple transactions on 2025-11-14 involving option exercises and open market sales of Cirrus Logic, Inc. (CRUS) stock.
• Exercised 595 options at $68.56 and 7,406 options at $78.00; both option grants were fully vested prior to exercise.
• Sold 595 shares at $117.44, 7,406 shares at a weighted average price of $119.39 (range: $117.78–$120.40), and an additional 912 shares at $117.44.
• Final direct beneficial ownership after the transactions is 5,950 shares.
• Transactions were executed under a Rule 10b5-1 trading plan adopted on 2025-08-15.
• Both exercised option grants now have 0 derivative securities remaining; original expirations were 2029-11-06 and 2031-03-03.

Sentiment

Score: 5

Explanation: Routine, plan-based insider exercise and sale; neutral signal with small net reduction in directly held shares.

Positives

• Trades were executed under a pre-established Rule 10b5-1 plan (adopted 2025-08-15), reducing concerns about opportunistic timing.
• Completion of exercises eliminated two option overhangs (remaining derivative balance now 0 for both grants).
• Insider retains 5,950 shares post-transaction, maintaining alignment with shareholders.

Negatives

• Net reduction of directly held shares by 912 (from 6,862 to 5,950) due to open market sale beyond exercised shares.
• Large single-day sale volume (8,913 shares) may be perceived negatively by some investors despite the 10b5-1 plan.
• Sales occurred near $117–$120 per share, suggesting monetization into strength.

Future Outlook

No forward-looking statements or guidance; transactions were conducted under a pre-arranged Rule 10b5-1 trading plan.

Management Comments

• Transactions were made pursuant to a Rule 10b5-1 plan adopted on 2025-08-15.
• The 7,406-share sale price was a weighted average; trades occurred between $117.78 and $120.40, and detailed breakdowns will be provided upon request.
• Only vested shares were exercisable; the $68.56 option fully vested by 2023-11-06 and the $78.00 option fully vested by 2025-03-03.

Industry Context

Plan-based insider exercises and sales are common across semiconductor peers as part of compensation and diversification; such transactions typically have minimal fundamental implications absent unusual size or timing.

Comparison to Industry Standards

• Comparable to insider 10b5-1 exercises/sales at semiconductor peers like Analog Devices (ADI) and Texas Instruments (TXN), where executives routinely exercise vested options and sell shares for diversification.
• Transaction size (8,913 shares) appears modest relative to typical executive Form 4 activity at mid-cap to large-cap analog/mixed-signal chipmakers and unlikely to be market-moving.

Stakeholder Impact

• Issuance of 8,001 shares from option exercises adds a small amount to shares outstanding (minor dilution).
• Insider retains 5,950 shares, maintaining some alignment with shareholders.
• Plan-based sales may reduce perceived governance risk around trading timing.

Key Dates

Recommendation

The activity is a standard 10b5-1 plan execution with modest size relative to CRUS’s float and no disclosed business updates; neutral for fundamentals, thus a hold based on this filing alone.

Keywords

Cirrus Logic, CRUS, Form 4, insider trading, Rule 10b5-1, stock options, option exercise, insider sale, Andrew Brannan, semiconductors